• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Device Problems Material Rupture (1546); Failure to Deflate (4060)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/26/2023
Event Type  malfunction  
Event Description
It was reported that the balloon would not deflate, then was believed to have broken.This 6.0 x 60mm, 135cm ranger paclitaxel-coated pta balloon catheter was selected for use in a vascular intervention procedure for peripheral artery disease.This device was inflated for three minutes during the procedure.Several different attempts were made to deflate the balloon for several minutes without success.Then it was believed that the balloon may have broken, and the balloon was able to be pulled back into the sheath and out of the patient.The procedure was completed and there were no patient complications.
 
Event Description
It was reported that the balloon would not deflate, then was believed to have broken.This 6.0 x 60mm, 135cm ranger paclitaxel-coated pta balloon catheter was selected for use in a vascular intervention procedure for peripheral artery disease.This device was inflated for three minutes during the procedure.Several different attempts were made to deflate the balloon for several minutes without success.Then it was believed that the balloon may have broken, and the balloon was able to be pulled back into the sheath and out of the patient.The procedure was completed and there were no patient complications.
 
Manufacturer Narrative
Device eval by manufacturer: upon receipt at our post market quality assurance laboratory,this 6.0 x 60mm, 135cm ranger paclitaxel-coated pta balloon catheter was visually and microscopically examined.Visual examination revealed multiple stretched sections along the inflation lumen.Microscopic examination revealed no additional damages.Functional testing was attempted but the damage prevented inflation testing.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis found damage that would have contributed to the failure to deflate but could not confirm the rupture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17469611
MDR Text Key320879105
Report Number2124215-2023-41756
Device Sequence Number1
Product Code ONU
UDI-Device Identifier08714729976103
UDI-Public08714729976103
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P190019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number08121H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/02/2023
Initial Date FDA Received08/07/2023
Supplement Dates Manufacturer Received08/24/2023
Supplement Dates FDA Received08/29/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/30/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-